Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Imprimis Pharmaceuticals has made available a customizable compounded formulation of pyrimethamine and leucovorin available for physicians to consider prescribing for their patients as a low cost alternative to Daraprim®.
read more
Imprimis Pharmaceuticals has announced that it has commenced construction on the company's Allen, Texas compounding pharmacy and plans to register the pharmacy with the U.S. Food and Drug Administration (FDA) as a 503B sterile outsourcing facility ...
read more
ImprimisRx has agreed to a product supply agreement with Vision Center Network of America (VCNA).
read more
Tuesday, December 10, 2019
ImprimisRx announced that on December 9, 2019, its FDA-registered 503B outsourcing facility received a non-resident operating license and has now begun shipping into California.
read more
ImprimisRx has agreed to a product supply agreement with iOR Partners.
read more
ImprimisRx has agreed to a product supply agreement with EyeCare Services Partners (ESP).
read more
IMS Health Holdings, Inc. and Quintiles Transnational Holdings Inc. have announced key senior management roles in the future Quintiles IMS corporate leadership team, subject to the completion of the merger.
read more
IMS Health and Quintiles have announced that their respective boards of directors approved a definitive merger agreement, pursuant to which the companies will be combined in an all-stock merger of equals transaction.
read more
IMS Health and Reltio have announced that IMS Health is offering Reltio Cloud with its Nexxus™ Commercial Application Suite and IMS One™ platform. Through the alliance, IMS Health will offer life sciences organizations new options for fast, scalable ...
read more
Inato has released its anticovid platform, a comprehensive, central repository for all existing clinical trials for SARS-CoV 2.
read more
Wednesday, March 29, 2017
goBalto, Inc., a provider of cloud-based clinical study startup solutions, announced results from its ongoing partnership with INC Research, a global CRO and pioneer in the implementation of goBalto's end-to-end study startup platform to accelerate ...
read more
INC Research Holdings a global Phase I to IV contract research organization, has announced the retirement of James T. Ogle as Chairman of the Board of Directors and as a Director of the Company. Mr. Ogle has been a member of the INC Research Board of...
read more
Wednesday, March 12, 2014
INC Research, a therapeutically focused global clinical research organization (CRO) with a Trusted Process® for delivering reliable results, today announced the appointment of Jane Winter as Senior Vice President, Global Consulting.
read more
INC Research, LLC, a therapeutically focused clinical research organization (CRO) with a Trusted Process® for delivering reliable results, today announced Christopher L. Gaenzle has joined the Company as its general counsel. Gaenzle will be part of ...
read more
Monday, February 13, 2017
INC Research Holdings, Inc., a global Phase I to IV contract research organization, has announced the appointment of Eric Paul Pâques, previously the Chief Executive Officer for GRÜNENTHAL GROUP, to the Company’s Board of Directors.
read more